Immune function determination in patients with bladder cancer.
作者信息
Brosman S A, Fahey J L
出版信息
Natl Cancer Inst Monogr. 1978 Dec(49):321-3.
PMID:311893
Abstract
Patients with bladder cancer were evaluated clinically for immune responsiveness and stage of disease. A battery of tests is described that attempts to correlate stage of disease with immune responsiveness.
摘要
相似文献
1
Immune function determination in patients with bladder cancer.
Natl Cancer Inst Monogr. 1978 Dec(49):321-3.
2
[T-cell bearing IgG-Fc receptor in patients with bladder cancer].
Hinyokika Kiyo. 1983 Dec;29(12):1625-9.
3
[The study of infiltrating lymphocytes in the tissues of bladder carcinoma].
Hinyokika Kiyo. 1983 Sep;29(9):1037-45.
4
[Adjuvant local BCG-immunotherapy in patients with urothel cancer of the bladder (author's transl)].
Wien Med Wochenschr. 1981 Oct 31;131(20):501-6.
5
[Immunocompetence and immunotherapy of patients with cancer of the kidney and bladder].
Urol Nefrol (Mosk). 1986 Jan-Feb(1):66-74.
6
The immunotherapy of prostate and bladder cancer.
BJU Int. 2005 Oct;96(5):728-35. doi: 10.1111/j.1464-410X.2005.05772.x.
7
Classification of the bladder cancer patient based on in vitro measurements of the immune response.
Cancer Res. 1977 Aug;37(8 Pt 2):2885-90.
8
[The intravesical administration of BCG vaccine in treating recurrent superficial bladder cancer].
Urol Nefrol (Mosk). 1997 Mar-Apr(2):29-32.
9
[Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
Urol Nefrol (Mosk). 1994 May-Jun(3):27-30.
10
[The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
Urol Nefrol (Mosk). 1996 Jan-Feb(1):19-21.
Zotero 插件